The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


How much Advair pain does GSK expect? Its 2017 forecast lays out the numbers

How does GSK's incoming chief view the Advair generic threat? Stay tuned this week

Teva's AirDuo steps up to challenge Advair, but the newcomer's fate depends on price

Novartis, late to the Advair generics party, urges FDA to block rival copycats

Phase III trial flop scuttles Vectura's hopes for expanding Flutiform into COPD

For the first time, GSK's respiratory newcomers offset Advair's decline

Teva's Advair rival joins the hopefuls gunning for GSK's blockbuster sales

Wannabe generic Advair makers Mylan, Vectura aim for 'rational' drug pricing

Novartis hopes Seretide-topping data can push docs toward Ultibro